Solid Tumor
Treatment stage |
Short Name |
Protocol Title |
ClinicalTrials.Gov Link |
Penn Research Coordinator |
Am I Eligible? |
|---|---|---|---|---|---|
| Advanced Solid Tumors | MYTHIC |
Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors |
NCT4855656 | Andrea Standish, RN | Eligibility Criteria |
| Advanced Solid Tumors | MAGNETIC | Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination with Gemcitabine for the Treatment of Advanced Solid Tumors | NCT05147272 | Andrea Standish, RN | Eligibility Criteria |
| Advanced Solid Tumors | FAETH | A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss | NCT05300048 | Katie Elkins |
Enrollment on Hold |
| Advanced Solid Tumors | ATRIN | A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors | NCT04905914 | Andrea Standish, RN | Eligibility Criteria |